PF 04418948
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 10mg | ¥772.00 | 现货 | |
| 50mg | ¥3181.00 | 现货 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
PF-04418948 is an orally active, potent and selective prostaglandin EP2 receptor antagonist with an IC50 of 16 nM.
Prostaglandin E2 (PGE2) induces distinct responses through four different ‘E prostanoid’ (EP) receptors. EP2 is a G protein-coupled receptor which signals preferentially through Gs proteins. It is far less active at other prostanoid receptors, including other EP receptors. PF-04418948 can be used in both cells and tissues.
In vitro, PF-04418948 inhibited prostaglandin E2 (PGE2)-induced growth in cAMP with a functional KB value of 1.8 nM in cells expressing EP2 receptors.
In vivo, in the case of human myometrium, PF-04418948 caused a parallel, rightward shift of the butaprost-induced inhibition of the contractions that was induced by electrical field stimulation with an apparent KB of 5.4 nM. In dog bronchiole and mouse trachea, it produced the same shifts of the PGE2-induced relaxation curve with a KB of 2.5 nM and an apparent KB of 1.3 nM respectively. Moreover, in the mouse trachea, reversal of the PGE2-induced relaxation by PF-04418948 produced an IC50 value of 2.7 nM.In rats, PF-04418948 significantly weakens the effects of the EP2-selective agonist butaprost on cutaneous blood flow when given orally. It was selective for EP2 receptors over homologous and unrelated receptors, enzymes and channels.
References:
1: af Forselles KJ, Root J, Clarke T, Davey D, Aughton K, Dack K, Pullen N. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist. Br J Pharmacol. 2011 Dec;164(7):1847-56. doi: 10.1111/j.1476-5381.2011.01495.x. Erratum in: Br J Pharmacol. 2012 Jun;166(3):1192. Dosage error in article text. PubMed PMID: 21595651; PubMed Central PMCID: PMC3246710.
2. Birrell MA, Maher SA, Buckley J, Dale N, Bonvini S, Raemdonck K, Pullen N, Giembycz MA, Belvisi MG. Selectivity profiling of the novel EP2 receptor antagonist, PF-04418948, in functional bioassay systems: atypical affinity at the guinea pig EP2 receptor. Br J Pharmacol. 2013 Jan;168(1):129-38. doi: 10.1111/j.1476-5381.2012.02088.x. PubMed PMID: 22747912; PubMed Central PMCID: PMC3570009.
3. Säfholm J, Dahlén SE, Delin I, Maxey K, Stark K, Cardell LO, Adner M. PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors. Br J Pharmacol. 2013 Feb;168(4):794-806. doi: 10.1111/j.1476-5381.2012.02189.x. PubMed PMID: 22934927; PubMed Central PMCID: PMC3631371
产品性质
| 物理外观 | A solid |
| CAS号 | 1078166-57-0 |
| 分子式 | C23H20FNO5 |
| 分子量 | 409.41 |
| 小分子别名 | PF-04418948 |
| 化学名称 | 1-(4-fluorobenzoyl)-3-(((6-methoxynaphthalen-2-yl)oxy)methyl)azetidine-3-carboxylic acid |
| 溶解度 | insoluble in EtOH; insoluble in H2O; insoluble in DMSO |
| SMILES | COc(cc1)cc(cc2)c1cc2OCC(C1)(CN1C(c(cc1)ccc1F)=O)C(O)=O |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | PF-04418948 是一种口服活性、强效和选择性前列腺素 EP2 受体拮抗剂,IC50 为 16 nM。 |



沪公网安备 31011002003500